James “J.D.” Derderian
J.D. Derderian has nearly three decades of experience working with Congressional and White House leadership.
J.D. is the founder and managing partner of the Stanton Park Group. His issue expertise is in healthcare, energy, technology, and telecommunications. As Chief of Staff to the House Committee on Energy and Commerce, Mr. Derderian served as the principal strategist and advisor to the Committee with jurisdiction over a wide array of economy drivers – healthcare, technology, energy, and finance. Mr. Derderian successfully guided passage of historic legislation such as the Food and Drug Administration Modernization, the Balanced Budget Act of 1997, and the Telecommunications Reform of 1996. In addition, he led the oversight of the many agencies and departments under the Committee’s purview such as the Department of Health and Human Services, the Department of Commerce, the Centers for Medicare and Medicaid Services, and the Food and Drug Administration.
Mr. Derderian graduated cum laude with a B.A. from the University of Richmond.
Lloyd K. Everson, M.D.
Dr. Everson served as President, Vice-Chairman and member of the Board of Directors of US Oncology, Inc. until is acquisition by McKesson Inc. in 2010. In 1993, Dr. Everson became a member of the Board of Directors, President, and Chief Operating Officer of American Oncology Resources, Inc., which was the predecessor organization of US Oncology, Inc.
From August 2013 until October, 2014, Dr. Everson served as President and CEO of Molecular Health, Inc.
Dr. Everson has served in numerous leadership roles in medical education throughout his career, including the practice of oncology and hematology, cancer research, academic and administrative medicine.
Dr. Everson graduated from Harvard Medical School in 1969. His postgraduate education included clinical and research positions at Cornell Medical Center & New York Hospital, NYC, NY, Memorial Sloan Kettering Cancer Center in NYC and at the National Cancer Institute in Washington, DC.
Caroline Jones Hubbell
Ms. Hubbell spent 20 years working in advertising both in Washington, D.C. and New York, N.Y. She served on the board of The Paper Bag Players and as a member of the Vestry at Grace Church New York City. Currently, Caroline works as an Admissions Associate at The Ethical Culture Fieldston School. She lives in Bronxville, NY.
Amit K. Sachdev
Mr. Sachdev serves as Vertex’s Executive Vice President, Policy, Access and Value, He manages the company’s global market access, health economics and outcomes research efforts for Vertex’s approved and pipeline medicines.
Mr. Sachdev also oversees Vertex’s government affairs and public policy activities, as well as the company’s patient advocacy programs. In 2010, he established our first international commercial operations.
Prior to Vertex, Mr. Sachdev served as Executive Vice President, Health, at the Biotechnology Industry Organization (BIO) and was Deputy Commissioner for Policy at the U.S. Food and Drug Administration (FDA) where he also held several other senior appointments beginning in 2002. Earlier in his career, Mr. Sachdev served as Majority Counsel to the Committee on Energy and Commerce in the U.S. House of Representatives and practiced law at the American Chemistry Council and subsequently at the law firm of Ropes & Gray.
Mr. Sachdev received a B.S from Carnegie Mellon University and a J.D. from Emory University School of Law.
Brian Duggan is Minority Owner/Board Member at Apex Clearing Corporation and also serves as Managing Member at Woodland & West, LLC, which offers investing and consulting services in the financial industry.
Previously, Mr. Duggan served for more than 22 years as CEO of Goldman Sachs Execution & Clearing, LP. While Head of Goldman Sachs Global Clearing business, Mr. Duggan provided professional trading clients access to all listed exchanges, financing and risk management for their strategies.
He is a graduate of Miami University, where he received a BS in Finance.